What We're Reading: Page 276
Industry reads hand-picked by our editors
May 29, 2018
-
The New York Times
Origins of an epidemic: Purdue Pharma knew its opioids were widely abused
-
The Boston Globe
For Boston’s brainy biotech crowd, there’s nothing like an early morning run
-
Bloomberg
China’s health-care stocks are scorching hot
-
Medical Marketing & Media
How drugmakers are facing the entrance of consumer giants into healthcare
May 25, 2018
-
Bloomberg
America is losing the race to develop the sunscreens of the future
-
Xconomy
Immunotherapy biotech Kiromic considers San Antonio move for cash
-
Regulatory Focus
Kickback allegation settlements pile up for pharmaceutical companies
-
Austin Business Journal
Law powerhouse Reed Smith plants roots in Austin, takes aim at biotech business
May 24, 2018
May 23, 2018
-
Bloomberg
Gene therapies that could transform diseases get easier FDA path
-
Chemical & Engineering News
$50 million more for CARB-X will help biotech companies fight antibiotic resistance
-
Los Angeles Times
New 'unified theory' of childhood leukemia raises possibility of preventing the disease
-
Associated Press
Many cancer patients juggle care along with financial pain
May 22, 2018
-
The New York Times
New cancer treatments lie hidden under mountains of paperwork
-
San Francisco Business Times
'Bursting at the seams,' this high-profile Peninsula biotech company is moving to a bigger home
-
Bloomberg
Deadly Chinese Fentanyl Is Creating a New Era of Drug Kingpins
Previous
